Abstract Coronavirus disease 2019 (COVID-19) is the second pandemic of the twenty-first
century, with over one-hundred million infections and over two million deaths to date. It is a …

The coronavirus disease-19 has left a permanent mark on the history of the human race.
Severe acute respiratory syndrome coronavirus-2 is a positive-sense single-stranded RNA …

Background The degree to which infection with SARS-CoV-2 confers protection towards
subsequent reinfection is not well described. In 2020, as part of Denmark's extensive, free-of …

The 501Y. V2 variants of SARS-CoV-2 containing multiple mutations in spike are now
dominant in South Africa and are rapidly spreading to other countries. Here, experiments …

Methods| Regulatory review with waiver of consent was completed by Cedars-Sinai Medical
Center (CSMC). From all samples from symptomatic inpatients and ambulatory care (urgent …

Despite the slow evolutionary rate of SARS-CoV-2 relative to other RNA viruses, its massive
and rapid transmission during the COVID-19 pandemic has enabled it to acquire significant …

Abstract Recently, the SARS-CoV-2 variants from the United Kingdom (UK), South Africa,
and Brazil have received much attention for their increased infectivity, potentially high …

Introduction As the global severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
pandemic continues to spread, several variants have emerged. Variants B. 1.1. 7 and B …

The current scenario, an ongoing pandemic of COVID-19, places a dreadful burden on the
healthcare system worldwide. Subsequently, there is a need for a rapid, user-friendly, and …

Background Monoclonal antibodies (mAbs) are laboratory‐produced molecules derived
from the B cells of an infected host. They are being investigated as a potential therapy for …